[1]
|
Bhattacharjye, A. S., & Sapra, P. K. (2008). Health insurance in China and India: Segmented roles for public and private financing. Health Affairs, 27, 1005-1015. doi:10.1377/hlthaff.27.4.1005
|
[2]
|
Chen, T., & Ye, X. (2007). Private health insurance and health actuary in mainland China. Proceedings of the 14th East Asian Actuarial Conference, Tokyo.
|
[3]
|
China annual incomes (2013).
http://money.cnn.com/2012/06/26/news/economy/china-middle-class/index.htm
|
[4]
|
China government announcement (2012).
http://www.google.com/search?q=ziyuanzhongxin+shujuziliao+book 335927+site:www.chira.org.cn
|
[5]
|
China healthcare reform (2012).
http://www.chira.org.cn/xinwenzhongxin/jiaodianxinwen/new337797.html
|
[6]
|
China Insurance Regulatory Commission (2013).
http://www.circ.gov.cn/web/site0/tab61/
|
[7]
|
China Insurance Regulatory Commission (2010).
http://www.circ.gov.cn/web/site0/tab211/i47326.htm
|
[8]
|
China Insurance Regulatory Commission (2013).
http://www.circ.gov.cn/web/site0/tab454/i191553.htm
|
[9]
|
Drechsler, D., & Jutting, J. (2007). Different countries, different needs: The role of private health insurance in developing countries. Journal of Health Politics, Policy and Law, 32, 497-534.
doi:10.1215/03616878-2007-012
|
[10]
|
Gordon, R., Xu, T., & Xie, L. (2012). Brazil’s health insurance.
http://www.google.com/search?safe=active&rlz=1T4MXGB_enUS546&q=Ronald+Gordon+and+Tian+Xu&oq=Ronald+Gordon+and+Tian+Xu& gs_l=serp.12..0i22i30.24027.62191.0.63861.56.40.0.0.0.0.3339.10282.0j1j4j2j6-1j0j1j2.11.0....0...1c.1.22.serp..46.10.10048.q8uuFXd4Z8s
|
[11]
|
Hougaard, J. L., ?sterdal, L. P., & Yu, Y. (2008). The Chinese health care system: Structure, problems and challenges. No. 08-01. Discussion papers department of Economics University of Copenhagen, Copenhagen.
|
[12]
|
Le Deu, F., Parekh, R., Zhang, F. N., & Zhou, G. (2012). Healthcare in China: “Entering uncharted waters”. New York: McKinsey & Company.
|
[13]
|
MOH China statistics (2012).
http://www.moh.gov.cn/publicfiles///business/cmsresources/mohwsbwstjxxzx/cmsrsdocument/doc15055.pdf
|
[14]
|
National development and reform commission, China. (2013).
http://shs.ndrc.gov.cn/ygid/ygwj/t200904080408_271138.htm
|
[15]
|
NRDL in 2009 (Chinese medicines listing) (2013).
http://www.china.com.cn/news/txt/2009-08/19/content_18359838.htm
|
[16]
|
OECD (2011). Health: Key table from OECD.
|
[17]
|
Private health insurance: Implications for developing countries. Discussion paper (2004). World Health Organization, Geneva.
|
[18]
|
Private Voluntary Health Insurance in Development (2007). World Bank, Washington DC.
|
[19]
|
Report on Health Insurance Development in China (2010). Beijing: China Insurance Regulatory Commission.
|
[20]
|
Roche to boost cancer drug sales in China with Swiss Re health insurance partnership. HIS. Global Insight (2012).
|
[21]
|
Sussmuth-Dyckerhoff, C., & Wang, J. (2010). China health care reforms. McKinsey. Health International.
|
[22]
|
Wang, J. X. et al. (2009). Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China. Chinese Journal of Hematology, 30, 721-725.
|
[23]
|
Whyte, M. K. (2010). Fair versus unfair: How do Chinese citizens view current inequalities? Growing pains: Tensions and opportunity in China’s transformation.
|
[24]
|
Wikipedia (2010) Health insurance.
http://en.wikipedia.org/wiki/Health_insurance
|